MAPT and Cognitive impairment: Similarly, the authors of one study show that plasma leptin levels are lower in subjects with mild cognitive impairment (MCI) or AD compared to control subjects and confirm a decrease in Aß42 and an increase in the tau protein related to MCI and AD.